Disease-Area Clinician - Trial Endpoints & Prescribing

• MD or DO with active clinical practice in the United States.
• Board certification in a relevant medical specialty.
• Active, unrestricted medical licensure in the United States.
• Deep clinical expertise in a specific therapeutic or disease area.
• Current or recent hands-on clinical practice within the relevant specialty.
• Familiarity with biotechnology and pharmaceutical drug-development programs.
• Strong understanding of clinical trials, endpoints, treatment outcomes, and evidence-based prescribing.
• Ability to translate complex clinical evidence into clear, structured written reasoning.
• Strong attention to detail and sound clinical judgment.

• → Develop and critically review evaluation rubrics for commercial drugs and drug-development programs.
• → Interpret clinical trial endpoints, study results, and efficacy/safety data within your area of specialty.
• → Assess whether clinical trial findings are meaningful from a practicing physician's perspective.
• → Evaluate whether trial outcomes are likely to influence prescribing decisions and clinical practice.
• → Assess the potential impact of clinical evidence on real-world treatment adoption and utilization.
• → Apply disease-area expertise to evaluate multiple drugs and development programs within the assigned therapeutic area.
• → Provide clear, evidence-based reasoning behind clinical assessments and recommendations.
• → Collaborate with other subject-matter experts to ensure evaluations are clinically rigorous, consistent, and grounded in current medical practice.

• Role: Disease-Area Clinician — Trial Endpoints & Prescribing
• Engagement: Paid pilot
• Duration: Approximately 10–20 hours over a 1–2 week period
• Location: Fully Remote
• Eligibility: US-based physicians
• Potential: Strong contributors may have opportunities for recurring engagements as the program expands.

• Apply your clinical expertise to help improve how AI systems evaluate pharmaceutical and clinical evidence.
• Contribute to more accurate, expert-level AI evaluation of drugs and drug-development programs.
• Work on a flexible, focused research engagement.
• Potential for continued opportunities based on project needs and performance.

• You will be engaged as an independent contractor.
• This is a fully remote opportunity with flexible scheduling.
• Projects may be extended, shortened, or concluded early depending on project requirements and performance.
• The engagement will not require access to confidential or proprietary information belonging to any employer, client, or institution.
• Payments are made weekly based on services rendered through available payment platforms.
• H-1B and STEM OPT candidates are not currently supported.

We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.